Parafibromin inhibits cancer cell growth and causes G1 phase arrest

被引:56
作者
Zhang, Chun
Kong, Dong
Tan, Min-Han
Pappas, Donald L., Jr.
Wang, Peng-Fei
Chen, Jindong
Farber, Leslie
Zhang, Nian
Koo, Han-Mo
Weinreich, Michael
Williams, Bart O.
Teh, Bin Tean [1 ]
机构
[1] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA
[2] Van Andel Res Inst, Lab Mammalian Dev Genet, Grand Rapids, MI 49503 USA
[3] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore
[4] Van Andel Res Inst, Lab Chromosome Replicat, Grand Rapids, MI 49503 USA
[5] Van Andel Res Inst, Lab Canc Pharmacogenet, Grand Rapids, MI 49503 USA
[6] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI 49503 USA
关键词
HRPT2; parafibromin; G1 phase arrest; cell cycle;
D O I
10.1016/j.bbrc.2006.08.169
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HRPT2 (hereditary hyperparathyroidism type 2) tumor suppressor gene encodes a ubiquitously expressed 531 amino acid protein termed parafibromin. Inactivation of parafibromin predisposes one to the development of HPT-JT syndrome. To date, the role of parafibromin in tumorigenesis is largely unknown. Here, we report that parafibromin is a nuclear protein that possesses anti-proliferative properties. We show that overexpression of parafibromin inhibits colony formation and cellular proliferation and induces cell cycle arrest in the G1 phase. Moreover, HPT-JT syndrome-derived mutations in HRPT2 behave in a dominant-negative manner by abolishing the ability of wild-type parafibromin to suppress cell proliferation. These findings suggest that parafibromin has a critical role in cell growth, and mutations in HRPT2 can directly inhibit this role. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 21 条
[1]   Genetics of endocrine tumours [J].
Calender, A. ;
Dupasquier, S. ;
Cordier, M. ;
Zhang, C. X. .
ANNALES DE PATHOLOGIE, 2005, 25 (06) :463-486
[2]   HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome [J].
Carpten, JD ;
Robbins, CM ;
Villablanca, A ;
Forsberg, L ;
Presciuttini, S ;
Bailey-Wilson, J ;
Simonds, WF ;
Gillanders, EM ;
Kennedy, AM ;
Chen, JD ;
Agarwal, SK ;
Sood, R ;
Jones, MP ;
Moses, TY ;
Haven, C ;
Petillo, D ;
Leotlela, PD ;
Harding, B ;
Cameron, D ;
Pannett, AA ;
Höög, A ;
Heath, H ;
James-Newton, LA ;
Robinson, B ;
Zarbo, RJ ;
Cavaco, BM ;
Wassif, W ;
Perrier, ND ;
Rosen, IB ;
Kristoffersson, U ;
Turnpenny, PD ;
Farnebo, LO ;
Besser, GM ;
Jackson, CE ;
Morreau, H ;
Trent, JM ;
Thakker, RV ;
Marx, SJ ;
Teh, BT ;
Larsson, C ;
Hobbs, MR .
NATURE GENETICS, 2002, 32 (04) :676-680
[3]  
Chang MP, 1999, MOL CELL BIOL, V19, P1056
[4]   Requirement of p27(Kip1) for restriction point control of the fibroblast cell cycle [J].
Coats, S ;
Flanagan, WM ;
Nourse, J ;
Roberts, JM .
SCIENCE, 1996, 272 (5263) :877-880
[5]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[6]   Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin [J].
Hahn, MA ;
Marsh, DJ .
ONCOGENE, 2005, 24 (41) :6241-6248
[7]   ADENOVIRUS-MEDIATED TRANSFER OF LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE ACUTELY ACCELERATES CHOLESTEROL CLEARANCE IN NORMAL MICE [J].
HERZ, J ;
GERARD, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2812-2816
[8]   HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours [J].
Howell, VM ;
Haven, CJ ;
Kahnoski, K ;
Khoo, SK ;
Petillo, D ;
Chen, J ;
Fleuren, GJ ;
Robinson, BG ;
Delbridge, LW ;
Philips, J ;
Nelson, AE ;
Krause, U ;
Hammje, K ;
Dralle, H ;
Hoang-Vu, C ;
Gimm, O ;
Marsh, DJ ;
Morreau, H ;
Teh, BT .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (09) :657-663
[9]   Loss of parafibromin expression in a subset of parathyroid adenomas [J].
Juhlin, C. ;
Larsson, C. ;
Yakoleva, T. ;
Leibiger, I. ;
Leibiger, B. ;
Alimov, A. ;
Weber, G. ;
Hoog, A. ;
Villablanca, A. .
ENDOCRINE-RELATED CANCER, 2006, 13 (02) :509-523
[10]   RNA polymerase II elongation factors of Saccharomyces cerevisiae:: a targeted proteomnics approach [J].
Krogan, NJ ;
Kim, M ;
Ahn, SH ;
Zhong, GQ ;
Kobor, MS ;
Cagney, G ;
Emili, A ;
Shilatifard, A ;
Buratowski, S ;
Greenblatt, JF .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) :6979-6992